 "WR News, Edition 3 (including Science Spin)")
|
Know the news.(READING COMPREHENSION/VOCABULARY)
|
How much have you learned from this issue? Fill in the circle for the best answer to each question.
1. Which of the following statements is most likely true?
(A) Earth will soon be renamed a dwarf planet.
(B) Many science textbooks will need to be rewritten.
(C) Pluto will stop circling the sun.
|
Gliatech Receives Allowance of U.S. Patent Claims for Anti-Properdin Technology.
PR Newswire
; ...patent claims covering the use of anti-properdin agents as treatments to inhibit harmful...developing therapeutic antibodies to properdin as potential treatments for acute inflammatory...our intellectual property around anti-properdin agents and their promising utility as...
|
|
Gliatech receives allowance of United States patent claiming therapeutic antibodies to properdin.(Brief Article)
Newspaper article from: BIOTECH Patent News
; ...patent claims covering the use of anti-properdin agents as treatments to inhibit harmful...developing therapeutic antibodies to properdin as potential treatments for acute inflammatory...our intellectual property around anti-properdin agents and their promising utility as...
|
|
GLIATECH, ABGENIX IN PROPERDIN ANTIBODY DEAL FOR UP TO $40M.(Brief Article)
Magazine article from: BIOWORLD Today
; ...license to develop and commercialize anti-properdin antibody therapies for all indications...monoclonal antibody therapies against properdin, a complement protein. Gliatech gets...technology to make antibodies targeted at the properdin antigen. Gliatech had been working in...
|
|
California Inventors Develop Anti-Properdin Antibodies
News Wire article from: US Fed News Service, Including US State News
; ...Calif., and Gerardo Zapata of San Mateo, Calif., have developed antibodies, and in particular, antibodies specific for properdin, the U.S. Patent & Trademark Office announced. The inventors were issued U.S. Patent No. 7,423,128 on Sept...
|
|
Research from Leiden University, Department of Nephrology provides new data on kidneys.
Newspaper article from: Biotech Week
; ...activation by tubular cells is mediated by properdin binding,' is now available. "Activation...activation indicate a key role for properdin in the initiation of an alternative pathway. We hypothesized that properdin serves as a focal point for complement...
|
|
New discovery on role of vital protein that fights meningitis.
Newspaper article from: Health & Medicine Week
; ...The study also reveals that the same protein, Properdin udiscovered only half a century ago- can also harm...the first line immune defence, a protein called Properdin. Properdin deficiency in families, though rare, predisposes...
|
|
Abgenix Licenses From Gliatech Antibody Product Candidates for Cardiovascular and Inflammatory Diseases; IND Planned for 2002.
Business Wire
; ...therapies against the complement protein properdin as potential treatments for cardiovascular...application to the FDA for an anti-properdin antibody product candidate next year...license to develop and commercialize anti-properdin antibody therapies for all indications...
|
|
Love, honor, draw blood ; At this wedding, the newlyweds and their guests all rolled up their sleeves to help find a genetic killer.
Newspaper article from: Sunday News Lancaster, PA
; ...their mother, said Morton, and that is properdin deficiency. The clinic sent the blood of the surviving cousin to be tested for properdin and found that it was missing. Once the clinic knew that properdin deficiency was the risk factor, said...
|
|
|
Gliatech's Monoclonal Antibody Indicates Potential in Myocardial Ischemia.
PR Newswire
; ...has previously shown that its anti-properdin MoAbs effectively block complement activation...In the most recent study, an anti- properdin MoAb was shown to significantly reduce...data further suggests that an anti-properdin MoAb may also have clinical utility in...
|
|
Monoclonal Antibody Has Potential in Reducing Heart Attack Damage.
Newspaper article from: Immunotherapy Weekly
; ...has previously shown that its anti-properdin MAbs effectively block complement activation...In the most recent study, an anti-properdin MAb was shown to significantly reduce...These data further suggest that an anti-properdin MAb may also have clinical utility in...
|
Find more facts and information related to the
article "Know the news.(READING COMPREHENSION/VOCABULARY)"
